442 related articles for article (PubMed ID: 23911232)
1. Strategies for protecting oligodendrocytes and enhancing remyelination in multiple sclerosis.
Rodgers JM; Robinson AP; Miller SD
Discov Med; 2013 Aug; 16(86):53-63. PubMed ID: 23911232
[TBL] [Abstract][Full Text] [Related]
2. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.
Keirstead HS; Blakemore WF
Adv Exp Med Biol; 1999; 468():183-97. PubMed ID: 10635029
[TBL] [Abstract][Full Text] [Related]
3. Remyelination: the true regeneration of the central nervous system.
Crawford AH; Chambers C; Franklin RJ
J Comp Pathol; 2013; 149(2-3):242-54. PubMed ID: 23831056
[TBL] [Abstract][Full Text] [Related]
4. Oligodendrocyte regeneration: Its significance in myelin replacement and neuroprotection in multiple sclerosis.
Chamberlain KA; Nanescu SE; Psachoulia K; Huang JK
Neuropharmacology; 2016 Nov; 110(Pt B):633-643. PubMed ID: 26474658
[TBL] [Abstract][Full Text] [Related]
5. Targeting CXCR7/ACKR3 as a therapeutic strategy to promote remyelination in the adult central nervous system.
Williams JL; Patel JR; Daniels BP; Klein RS
J Exp Med; 2014 May; 211(5):791-9. PubMed ID: 24733828
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of remyelination: recent insight from experimental models.
Tanaka T; Yoshida S
Biomol Concepts; 2014 Aug; 5(4):289-98. PubMed ID: 25372760
[TBL] [Abstract][Full Text] [Related]
7. Enhancing remyelination in disease--can we wrap it up?
Kotter MR; Stadelmann C; Hartung HP
Brain; 2011 Jul; 134(Pt 7):1882-900. PubMed ID: 21507994
[TBL] [Abstract][Full Text] [Related]
8. Remyelination in multiple sclerosis: cellular mechanisms and novel therapeutic approaches.
Olsen JA; Akirav EM
J Neurosci Res; 2015 May; 93(5):687-96. PubMed ID: 25287108
[TBL] [Abstract][Full Text] [Related]
9. Recent Advances on Immunosuppressive Drugs and Remyelination Enhancers for the Treatment of Multiple Sclerosis.
Cadenas-Fernández J; Ahumada-Pascual P; Andreu LS; Velasco A
Curr Pharm Des; 2021 Oct; 27(30):3273-3280. PubMed ID: 33504299
[TBL] [Abstract][Full Text] [Related]
10. Cellular approaches for stimulating CNS remyelination.
Miller RH; Bai L
Regen Med; 2007 Sep; 2(5):817-29. PubMed ID: 17907933
[TBL] [Abstract][Full Text] [Related]
11. Revisiting remyelination: Towards a consensus on the regeneration of CNS myelin.
Franklin RJM; Frisén J; Lyons DA
Semin Cell Dev Biol; 2021 Aug; 116():3-9. PubMed ID: 33082115
[TBL] [Abstract][Full Text] [Related]
12. Remyelinating strategies: What can be learned from normal brain development.
Shelestak J; Irfan M; DeSilva TM
Curr Opin Pharmacol; 2022 Dec; 67():102290. PubMed ID: 36195009
[TBL] [Abstract][Full Text] [Related]
13. Remyelination - An effective means of neuroprotection.
Bruce CC; Zhao C; Franklin RJ
Horm Behav; 2010 Jan; 57(1):56-62. PubMed ID: 19538961
[TBL] [Abstract][Full Text] [Related]
14. A dual effect of ursolic acid to the treatment of multiple sclerosis through both immunomodulation and direct remyelination.
Zhang Y; Li X; Ciric B; Curtis MT; Chen WJ; Rostami A; Zhang GX
Proc Natl Acad Sci U S A; 2020 Apr; 117(16):9082-9093. PubMed ID: 32253301
[TBL] [Abstract][Full Text] [Related]
15. Promotion of Remyelination by Sulfasalazine in a Transgenic Zebrafish Model of Demyelination.
Kim S; Lee YI; Chang KY; Lee DW; Cho SC; Ha YW; Na JE; Rhyu IJ; Park SC; Park HC
Mol Cells; 2015 Nov; 38(11):1013-21. PubMed ID: 26549504
[TBL] [Abstract][Full Text] [Related]
16. Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo.
Najm FJ; Madhavan M; Zaremba A; Shick E; Karl RT; Factor DC; Miller TE; Nevin ZS; Kantor C; Sargent A; Quick KL; Schlatzer DM; Tang H; Papoian R; Brimacombe KR; Shen M; Boxer MB; Jadhav A; Robinson AP; Podojil JR; Miller SD; Miller RH; Tesar PJ
Nature; 2015 Jun; 522(7555):216-20. PubMed ID: 25896324
[TBL] [Abstract][Full Text] [Related]
17. Seeing is believing: Identifying remyelination in the central nervous system.
Hill MFE; Cunniffe NG; Franklin RJM
Curr Opin Pharmacol; 2022 Oct; 66():102269. PubMed ID: 35926475
[TBL] [Abstract][Full Text] [Related]
18. Immune promotion of central nervous system remyelination.
Rodriguez M; Miller DJ
Prog Brain Res; 1994; 103():343-55. PubMed ID: 7886217
[TBL] [Abstract][Full Text] [Related]
19. Remyelination in multiple sclerosis: realizing a long-standing challenge.
Aharoni R
Expert Rev Neurother; 2015; 15(12):1369-72. PubMed ID: 26558886
[TBL] [Abstract][Full Text] [Related]
20. Oligodendrocyte Regeneration and CNS Remyelination Require TACE/ADAM17.
Palazuelos J; Klingener M; Raines EW; Crawford HC; Aguirre A
J Neurosci; 2015 Sep; 35(35):12241-7. PubMed ID: 26338334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
